Abstract
To assess efficacy and safety of chloroquine (CQ)/hydroxychloroquine (HCQ) for treatment or prophylaxis of COVID-19 in adult humans. MEDLINE, PubMed, EMBASE and two pre-print repositories (bioRxiv, medRxiv) were searched from inception to 8th June 2020 for RCTs and nonrandomized studies (retrospective and prospective, including single-arm, studies) addressing the use of CQ/HCQ in any dose or combination for COVID-19. Thirty-two studies were included (6 RCTs, 26 nonrandomized, 29,192 participants). Two RCTs had high risk, two 'some concerns' and two low risk of bias (Rob2). Among nonrandomized studies with comparators, nine had high risk and five moderate risk of bias (ROBINS-I). Data synthesis was not possible. Low and moderate risk of bias studies suggest that treatment of hospitalized COVID-19 with CQ/HCQ may not reduce risk of death, compared to standard care. High dose regimens or combination with macrolides may be associated with harm. Postexposure prophylaxis may not reduce the rate of infection but the quality of the evidence is low. Patients with COVID-19 should be treated with CQ/HCQ only if monitored and within the context of high quality RCTs. High quality data about efficacy/safety are urgently needed.
Citations
Jul 14, 2020·Infectious Diseases·Mihai OlteanKristjan Karason
Jul 6, 2020·Expert Review of Clinical Immunology·Sebastian E SattuiJeffrey A Sparks
Aug 7, 2020·American Journal of Physiology. Endocrinology and Metabolism·Emile LevySchohraya Spahis
Aug 18, 2020·Critical Care Medicine·Nicole EvangelidisUNKNOWN COVID-19-Core Outcomes Set (COS) Survey Investigators
Oct 14, 2020·British Journal of Clinical Pharmacology·Daniela R Junqueira, Brian H Rowe
Dec 3, 2020·Tropical Medicine and Infectious Disease·Saad AlhumaidMansour Tobaiqy
Jan 17, 2021·Clinical Biochemistry·Raúl Rigo-Bonnin, Francesca Canalias
Jan 14, 2021·Avicenna Journal of Medicine·Hatem A Hejaz
Sep 6, 2020·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Ali J Marian
Nov 24, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Bianza Moise BakadiaGuang Yang
Feb 4, 2021·International Journal of General Medicine·Xiaozhou FanRahul Khanna
Dec 29, 2020·Clinical Case Reports·Massimo DonzelliAndrea Cortegiani
Jan 30, 2021·RMD Open·Claudia Diniz Lopes MarquesAna Paula Monteiro Gomides Reis
Nov 25, 2020·Clinical Case Reports·Manoon SurabotsophonVarunee Desakorn
Feb 27, 2021·Journal of Public Health Research·Alhassane DialloChristophe Jedrecy
Mar 12, 2021·Reviews in Medical Virology·Xizhong CuiParizad Torabi-Parizi
Mar 31, 2021·Expert Review of Anti-infective Therapy·Praveen Kumar-MSamir Malhotra
Apr 25, 2021·Scientific Reports·Alaa RashadHamed Elgendy
Apr 27, 2021·Journal of Diabetes and Its Complications·Antonio Ceriello, Francesco Prattichizzo
Oct 3, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·A J J LammersP H P Groeneveld
May 18, 2021·Frontiers in Microbiology·Kaho ShionoyaKoichi Watashi
May 29, 2021·Annals of Global Health·Matheus Negri BoschieroFernando Augusto Lima Marson
Jun 1, 2021·Frontiers in Microbiology·Subhajit Maity, Abhik Saha
Jun 10, 2021·PloS One·Anis SaibLee S Nguyen
Nov 23, 2020·Research in Social & Administrative Pharmacy : RSAP·Joshua D BrownTodd M Manini
Oct 11, 2020·Journal of Hepatology·Tarik AsselahRaymond F Schinazi
Oct 9, 2021·Advances in Rheumatology·Gecilmara Salviato PileggiMarcelo Medeiros Pinheiro